Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 262

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 262
---
 In consideration of the interests set forth below, FutureTech’s
directors and officers also engaged an independent investment banking firm that rendered an opinion with respect to the fairness of the
Merger Consideration to FutureTech and its unaffiliated stockholders from a financial point of view, which the members of the
FutureTech Board factored into their decision to approve the Merger Agreement. For more information regarding the opinion, see the section
titled “Proposal No. 1 — The Business Combination Proposal — Opinion of Newbridge.” Additionally, the members
of the FutureTech Board determined that these interests could be adequately disclosed to stockholders in this proxy statement/prospectus
and that FutureTech stockholders could take them into consideration when deciding whether to vote in favor of the proposals set forth
herein. These interests include, among other things, the interests listed below:

FutureTech’s
existing directors and officers will be eligible for continued indemnification and continued coverage under FutureTech’s directors’
and officers’ liability insurance after the Mergers and pursuant to the Merger Agreement.

The Sponsor Persons have agreed
to vote in favor of the Business Combination, regardless of how FutureTech’s public stockholders vote. Unlike some other blank
check companies in which the initial stockholders agree to vote their founder shares in accordance with the majority of the votes cast
by the public stockholders in connection with an initial business combination, the Sponsor Persons have agreed to, among other things,
vote in favor of the Merger Agreement and the transactions contemplated thereby. As of the date of this proxy statement/prospectus, the
Sponsor Persons own approximately 79.1% of the issued and outstanding shares of FutureTech Common Stock.

The Sponsor and
FutureTech’s directors, officers, advisors or their respective affiliates may purchase shares or warrants in privately negotiated
transactions or in the open market either prior to or following the completion of the Business Combination. However, they have no current
commitments, plans or intentions to engage in any such transactions and have not formulated any terms or conditions for any such transactions.
None of the funds in the Trust Account will be used to purchase shares or warrants in such transactions. If any such persons engage in
such transactions, they will not make any such purchases when they are in possession of any material non-public information not disclosed
to the seller or if such purchases are prohibited by Regulation M under the Exchange Act or other federal securities laws. Such a purchase
may include a contractual acknowledgement that such stockholder, although